Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
David Fitz-Patrick, Kent Roberson, Kiyoshi Niwa, Takabumi Fujimura, Koji Mori, Jesse Hall, Xiaohong Yan, Zancong Shen, Sha Liu, Yasushi Ito & Scott Baumgartner. (2019) Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials. Modern Rheumatology 29:6, pages 1042-1052.
Read now
Read now
Paul P. Doghramji, Steve Fermer, Robert Wood, Robert Morlock & Scott Baumgartner. (2016) Management of gout in the real world: current practice versus guideline recommendations. Postgraduate Medicine 128:1, pages 106-114.
Read now
Read now
Articles from other publishers (15)
Till Uhlig, Lars F Karoliussen, Joe Sexton, Sella Aarrestad Provan, Tore K Kvien, Espen A Haavardsholm & Hilde Berner Hammer. (2023) Course and predictors of work productivity in gout — results from the NOR-Gout longitudinal 2-year treat-to-target study. Rheumatology 62:12, pages 3886-3892.
Crossref
Crossref
Alyssa Howren, Drew Bowie, Hyon K. Choi, Sharan K. Rai & Mary A. De Vera. (2021) Epidemiology of Depression and Anxiety in Gout: A Systematic Review and Metaanalysis. The Journal of Rheumatology 48:1, pages 129-137.
Crossref
Crossref
Yen-Huai Lin, Hsi-Chung Chen, Nai-Wei Hsu & Pesus Chou. (2020) Validation of Global Self-Rated Health and Happiness Measures Among Older People in the Yilan Study, Taiwan. Frontiers in Public Health 8.
Crossref
Crossref
María Presa, Fernando Pérez-Ruiz & Itziar Oyagüez. (2019) Second-line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients. Clinical Rheumatology 38:12, pages 3521-3528.
Crossref
Crossref
Weixian Lee, Gim Gee Teng, Joon Chong Kok, Amelia Santosa, Anita Y. N. Lim & Hwee‐Lin Wee. (2019) Validity and reliability of the Gout Impact Scale in a multi‐ethnic Asian population. International Journal of Rheumatic Diseases.
Crossref
Crossref
Theodore R. Fields. (2019) The Challenges of Approaching and Managing Gout. Rheumatic Disease Clinics of North America 45:1, pages 145-157.
Crossref
Crossref
Sarah Stewart, Keith Rome, Alastair Eason, Meaghan E. House, Anne Horne, Anthony J. Doyle, Julie Knight, William J. Taylor & Nicola Dalbeth. (2018) Predictors of activity limitation in people with gout: a prospective study. Clinical Rheumatology 37:8, pages 2213-2219.
Crossref
Crossref
Roy Fleischmann, Peter Winkle, Jesse Hall, Shakti Valdez, Sha Liu, Xiaohong Yan, Liz Hicks, Caroline Lee, Jeffrey N Miner, Michael Gillen & Martha Hernandez-Illas. (2018) Pharmacodynamic and pharmacokinetic effects and safety of verinurad in
combination with febuxostat in adults with gout: a phase IIa, open-label
study. RMD Open 4:1, pages e000647.
Crossref
Crossref
Theodore R. Fields & Adena Batterman. (2018) How Can We Improve Disease Education in People with Gout?. Current Rheumatology Reports 20:3.
Crossref
Crossref
Theodore R. Fields, Adam Rifaat, Arthur M.F. Yee, Dalit Ashany, Katherine Kim, Matthew Tobin, Nicole Oliva, Kara Fields, Monica Richey, Shanthini Kasturi & Adena Batterman. (2017) Pilot study of a multidisciplinary gout patient education and monitoring program. Seminars in Arthritis and Rheumatism 46:5, pages 601-608.
Crossref
Crossref
Paul S. J. Miller, Harry Hill & Fredrik L. Andersson. (2016) Nocturia Work Productivity and Activity Impairment Compared with Other Common Chronic Diseases. PharmacoEconomics 34:12, pages 1277-1297.
Crossref
Crossref
Robert Wood, Steve Fermer, Sulabha Ramachandran, Scott Baumgartner & Robert Morlock. (2016) Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity. The Journal of Rheumatology 43:10, pages 1897-1903.
Crossref
Crossref
Martijn A.H. Oude Voshaar, Thomas Bardin & Martinus A.F.J. van de Laar. (2015) The Human and Economic Burden of Difficult-to-Treat Gouty Arthritis. Joint Bone Spine 82, pages eS2-eS8.
Crossref
Crossref
Gemma E. Shields & Stephen M. Beard. (2015) A Systematic Review of the Economic and Humanistic Burden of Gout. PharmacoEconomics 33:10, pages 1029-1047.
Crossref
Crossref
Gail S. Kerr, John S. Richards, Carl A. Nunziato, Olga V. Patterson, Scott L. DuVall, Mireille Aujero, David Maron & Richard Amdur. (2015) Measuring Physician Adherence With Gout Quality Indicators: A Role for Natural Language Processing. Arthritis Care & Research 67:2, pages 273-279.
Crossref
Crossref